Company Overview

Company name: Canandia
Description: Producer of cannabis specialty strains for medical and recreational markets. The company offers a variety of pharmaceutical grade cannabidiols, solids, and other related products.
Year founded: 2001
Parent company: Invictus MD
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Delta
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by Invictus MD (TSX: GENE) for CAD 29.4 million on November 16, 2018. The acquisition will enable the acquirer to strengthen its ability to control a steady supply of cannabis to medical and recreational markets.
Number of active investors:
Profile last updated: 21-Nov-2018
Last known valuation: 22.55
Last known valuation date: 16-Nov-2018